of T channels remains less certain (Llinas, 1988; Huguenard, 1996 fields of these neurons. We provide evidence that reducThis hyperalgesia is blocked by the oxidizing agent ing agents, including dithiothreitol (DTT) and the endog-5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) and the T enous amino acid L-cysteine, promote cutaneous therchannel antagonist mibefradil. DTNB alone and in mal and mechanical hyperalgesia via effects on T combination with mibefradil induces thermal analgechannels. Conversely, the oxidizing agent 5,5Ј-dithiosia. Likewise, L-cysteine induces mechanical DTNBbis-(2-nitrobenzoic acid) (DTNB) and T-type calcium sensitive hyperalgesia in peripheral receptive fields. channel antagonist mibefradil produce analgesia to cuThese data strongly suggest a role for T channels in taneous thermal stimuli. The results demonstrate a novel peripheral nociception. Redox sites on T channels in role for peripheral T-type Ca 2ϩ channels in boosting noperipheral nociceptors could be important targets for ciceptive signals. In addition, these results suggest a agents that modify pain perception. potential role for endogenous or exogenous redox agents in the modulation of pain sensation. Introduction 
regulate the excitability of nociceptive cells. We found Ϫ35mV, the inactivation time constant () was 50 Ϯ 3.7 ms in control and 25.5 Ϯ 1.6 ms in the presence of DTT that the reducing agent DTT (0.1 and 1 mM), at a test potential of Ϫ35mV, selectively augmented T-type Ca 2ϩ (n ϭ 5, p Ͻ 0.01). We also examined whether increasing the temperature of in vitro experiments to 37ЊC (the currents by 128% Ϯ 16% (n ϭ 14) and 142% Ϯ 18% (n ϭ 11), respectively, while leaving HVA Ca 2ϩ currents normal in vivo temperature) altered responses to reducing agents, since higher temperatures are likely to inin the same cells unaffected (n ϭ 5 for 0.1 mM, and n ϭ 7 for 1 mM; Figures 1A and 1B) . In all, DTT enhanced T crease the amplitude of T currents and accelerate activation and inactivation kinetics in the absence of redox currents in 34 of 39 cells (86%), and this effect was completely reversible within 2 min after removal of DTT. modulation. At 37ЊC, 0.1 mM DTT increased peak T currents about 2-fold, similar to the effect observed at 22ЊC. An apparent steady-state effect was observed with up to 1 min application of DTT (0.1-1 mM), and no change However, changes in current kinetics with DTT were less apparent at higher temperatures (n ϭ 3; data not shown). in maximal effect was observed with longer applications up to 5 min (n ϭ 3; data not shown). The effect of DTT We also examined the effects of DTT upon voltagegated K ϩ and Na ϩ currents in small-size sensory neuon T currents was accompanied by a change in current kinetics. Activation times, measured as the 10%-90% rons. Figure 1C illustrates the lack of effect of 4 mM DTT on inward Na ϩ currents in these cells (n ϭ 7), and rise times of peak currents, were accelerated in the presence of DTT. At Ϫ35mV, the control 10%-90% rise Figure 1D shows the lack of effect of 3 mM DTT on a family of outward potassium currents (n ϭ 5). time was 17.2 Ϯ 2.5 ms, and in the presence of DTT it was 10.1 Ϯ 1.4 ms (mean Ϯ SEM, n ϭ 5, p Ͻ 0.05). At T channels are heterogeneously expressed in DRG an average of 2.5-fold (157% Ϯ 50% increase for 0.1 nociception. However, up to 3 mM DTT had no effect mM DTT, n ϭ 5; Figure 2E ). Similar to DRG cells, the on capsaicin-induced currents (1% Ϯ 4% change, n ϭ increased current was accompanied by acceleration of 6; Figure 1E ). To test the sensitivity of heat channels to activation and inactivation kinetics ( Figure 2E ). The ef-DTT, we applied heated external solution (45ЊC Ϯ 2ЊC) fects of DTT were mimicked by L-cysteine (n ϭ 2). Also, to these cells. Nineteen small DRG cells were studied, similar to DRG cells, 1 mM DTNB blocked Ca v 3.2 curand ten of them (53%) responded with inward currents, rents by 50% Ϯ 3.4% (n ϭ 7; Figure 2E ), without signifias depicted in Figure 1E . All DRG neurons responded cant effect on current kinetics, while 3 mM DTNB comto low pH (pH 5.3, n ϭ 9), but only 3 of 15 cells (20%) pletely blocked these currents in HEK cells (n ϭ 6). On responded to 100 M ATP. Currents elicited by heat, average, the control 10%-90% rise time at a V t of Ϫ30mV low pH, and ATP were not significantly altered by 1-3 was 8 Ϯ 0.9 ms, and the control inactivation was 24.7 Ϯ mM DTT ( Figure 1E ). These data strongly suggest that 2 ms. In the presence of DTT, rise time was 4.9 Ϯ 0.7 DTT selectively modulates T-type Ca 2ϩ currents in capms (p Ͻ 0.05), and inactivation was 15.8 Ϯ 2 ms (n ϭ saicin-sensitive sensory neurons but not other voltage-9, p Ͻ 0.05). In the presence of 1 mM DTNB, these times gated currents or channels thought to mediate heat or were 7.7 Ϯ 0.9 ms and 28 Ϯ 5 ms (n ϭ 6, p Ͼ 0.05), chemical sensitivity.
respectively. At lower concentrations, DTNB fully reIf reducing agents enhance currents through T-type versed effects of DTT on current kinetics (n ϭ 3; data Ca 2ϩ channels, we would expect that oxidizing agents not shown), peak current amplitude, and time course of should decrease current flow through these channels. recovery ( Figure 2F ). The average half-time for the fully Indeed, application of 1 mM DTNB blocked peak T curreduced Ca v 3.2 channel to spontaneously return to rents by about 50% (46% Ϯ 2.7%, n ϭ 9) in all tested baseline levels was 83 Ϯ 12 s in control conditions and cells ( Figure 2B ) and, when applied immediately after 43 Ϯ 3 s in the presence of 0.1 mM DTNB (n ϭ 3, p Ͻ DTT, reversed the effects of DTT on current kinetics 0.05). These results suggest that Ca v 3.2 T-type channels, (n ϭ 5; Figure 2A ). In contrast to DTT, DTNB did not the predominant isoform in sensory neurons (Talley et significantly affect the time course of activation or inactial., 1999), have sensitivity to redox agents similar to vation (at Ϫ35mV, the 10%-90% rise time was 17 Ϯ 4.5 native DRG cells. ms, and the inactivation was 50.7 Ϯ 5.3 ms, n ϭ 4, p Ͼ 0.05). The half-time for spontaneous recovery from In Vivo Studies DTNB was 26 Ϯ 2.5 s (n ϭ 5; Figure 2B ). However, if Because redox agents modulate T currents in isolated 10 M DTT was added immediately after DTNB, half neurons that participate in thermal nociception, we exrecovery was achieved in only 13 Ϯ 3 s (p Ͻ 0.05, n ϭ amined whether these agents modify in vivo responses 3). The inhibition of peak currents by DTNB was selective to radiant thermal ( Figure 4B ). Moreover, a higher dose of DTNB (40 g/100 l) prolonged PWLs, injected 25 g/100 l of ketamine, a noncompetitive NMDAR antagonist, into hindpaws and found that ketaindicating an analgesic effect ( Figure 4B ). At 10 min following injection, DTNB increased the latency time by mine neither altered thermal PWLs (n ϭ 8) nor affected the thermal hyperalgesia induced by DTT (n ϭ 8; data 4.3 s (p Ͻ 0.0005, n ϭ 12). This analgesic effect was completely reversed by 1.5 g/100 l DTT, which had not shown). Also, intraplantar injections of a competitive NMDAR antagonist, D-APV (4 g/100 l), did not affect no effect on its own (n ϭ 6; data not shown). Dimethyl sulfoxide (DMSO) (1%), the vehicle used to dissolve baseline thermal nociception (n ϭ 8) or L-cysteineinduced thermal hyperalgesia (n ϭ 6; data not shown).
DTNB, had no effect on PWLs ( Figure 4A ) and did not interfere with the effects of the reducing agents (n ϭ 6; In prior studies, ketamine (2.5 g/100 l) and AP-7 (4 g/100 l) injected locally attenuated the development data not shown). of thermal hyperalgesia and allodynia associated with subacute joint inflammation ( as general amplifiers of peripheral nociception, these to the ventral side of the hindpaw, causes nociceptive behavior (measured as the number of paw withdrawals channels would be expected to be involved in pain sensation generated through other modalities. We therefore per ten trials). These withdrawal responses were compared in injected and noninjected paws before (baseline tested the possibility that mechanical sensation could also be modulated by redox agents injected in peripheral and 0 min), 10, and 60 min following injection of 100 l of redox agents in hindpaws. Figure 5A indicates that receptive fields of sensory neurons. We first determined the size of von Frey filament (4.93), which, when applied injections of saline or 1% DMSO did not cause any 6C ; n ϭ withdrawal responses by 2.6-fold after 10 min (p Ͻ 0.0001, n ϭ 8 animals). When 40 g/100 l of DTNB was 8 for L-cysteine, and n ϭ 14 animals for DTT). These results are consistent with the idea that the injected ( Figure 5C ), withdrawal responses after 10 min indicated an analgesic effect (60% less than control, hyperalgesic responses to reducing agents result from modulation of T channels in nociceptors. However, we p Ͻ 0.01, n ϭ 12 animals). A lower dose of DTNB (4 g/100 l) had little effect on its own but completely were surprised that mibefradil alone had no effect on thermal PWLs yet blocked the effects of L-cysteine and reversed the hyperalgesic effect of L-cysteine ( Figure  5D ; n ϭ 8, p Ͼ 0.05). Similarly, a lower dose of L-cysteine DTT, given that DTNB had analgesic effects at higher doses and also inhibited DRG T currents. This led us completely reversed the analgesic effects of DTNB (n ϭ 8; data not shown). These data indicate that redox to examine interactions between mibefradil and redox agents in vitro. Figure Figure 7B shows an exand Bean, 1998). In DRG neurons, we previously found that mibefradil is one of the most potent blockers of T periment in which a subthreshold concentration of DTNB (0.2 mM) enhanced the block of T currents by currents yet described, with an IC 50 of 3 M (Todorovic and Lingle, 1998). In vivo, injection of 6 g/100 l mibe-1 M mibefradil by about 2-fold. On average, 1 M mibefradil alone blocked 23.7% Ϯ 1.5%, while the comfradil into rat hindpaws had no significant effect on thermal PWLs (n ϭ 12 animals; Figure 6A ). We were unable to bination of 1 M mibefradil and 0.2 mM DTNB blocked 49.2% Ϯ 1.1% of the current (p Ͻ 0.001, n ϭ 4). Consisexamine doses of mibefradil above 6 g/100 l because mibefradil injections caused hyperemia and increases in tent with this, 0.2 mM DTNB shifted the mibefradil IC 50 to 1.1 M ( Figure 7C ). skin temperature, presumably due to local vasodilating sensory neurons. The oxidizing agent DTNB, which is also relatively membrane impermeant (Aizenman et al., 1989; Tang and Aizenman, 1993), blocks T currents on its own at higher concentrations and, at lower concentrations, reverses the effects and speeds recovery from the effects of the reducing agents. DTT and L-cysteine produce prominent changes in T current kinetics, as evidenced by acceleration of both activation and inactivation. In contrast, DTNB had little effect on current kinetics. This suggests the existence of putative extracellular redox sites that modulate T channels in rat sensory neurons. Furthermore, spontaneous recovery from the oxidizing effect of DTNB (which results in the formation of relatively stable disulfide bonds or thiobenzoate-proteins) implies the existence of an unknown endogenous reducing factor that has access to peripheral nociceptive pathways.
Since DTT, DTNB, and L-cysteine are all highly selective redox agents for thiol groups on proteins, the redox sites in rat sensory neurons could involve any of the many L-cysteine residues present in putative extracellular regions of T channels ( 
Mechanisms of T-Type Ca 2؉ Current Modulation channel antagonist mibefradil. Additionally, D-APV, keby Redox Agents
tamine, and MK-801 injected into peripheral receptive We provide evidence that the extracellular reducing agents DTT and L-cysteine augment T currents in rat fields alone in our study had no effect on baseline ther- It is possible that in some pathological conditions of nociceptive endings is unknown, it is possible that inflammation, burns, tissue hematoma, or trauma result there is cross-talk between redox modulation of T channels and channels that are thought to be peripheral in plasma extravasation and local accumulation of L-cysteine and other thiol-containing amino acids in nociceptive transducers. However, we found no effect of reducing agents on currents elicited by heat, acidic proximity to putative nociceptive endings. We show here that direct injection of L-cysteine into peripheral resolutions, or ATP. Our results suggest that tissue conditions that favor a more reducing extracellular environceptive fields induces hyperalgesia to thermal and mechanical stimuli. It is possible that other thiol-containing ment enhance T channel function and boost signals generated from putative nociceptive endings to the spicompounds like L-homocysteine or glutathione could also be endogenous redox modulators of T channels nal cord. Thus, T channels may contribute to neuronal 0.5% for in vitro experiments. At these concentrations, DMSO had no effect on either T currents or holding potential (data not shown).
Experimental Procedures
Mibefradil ( 
